US › Healthcare

Fortrea Holdings Inc. (FTRE)

US · Healthcare · Biotechnology

$17.99-5.02%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$678.2M
Revenue YoY
-4.5%
Net profit
$-13.2M
Profit YoY
+96.5%
EPS
$0.23
EPS estimate
$0.18
Net margin
-1.9%

EPS came in at 0.23 against a street estimate of 0.18 — a beat of 27.8%.

Key statistics

Market cap
$1.82B
Forward P/E
15.0
P/B
3.48
Book value
$5.56
EPS (TTM)
$-0.83
52-week high
$21.39
52-week low
$5.82
50-day MA
$16.93
200-day MA
$13.64
Beta
2.01

Analyst view

Analysts rate Fortrea Holdings Inc. a hold (1 buy, 10 hold, 1 sell out of 12) with an average price target of $20.18.

Shareholding

Insiders
1.01%
Institutions
110.42%

Largest institutional holders

FundStake
BlackRock Inc15.93%
The Goldman Sachs Group Inc8.52%
Corvex Management LP4.88%
Sessa Capital, L.P4.83%
State Street Corp4.32%
Vanguard Capital Management, LLC4.25%
Vanguard Portfolio Management, LLC3.89%
AQR Capital Management LLC3.47%

Recent filings & reports

DocumentDate
Quarterly report · Q2 20262026-07-29
Results announced · Q3 20262026-07-29
Board / officer change · Q3 20262026-07-14
Board / officer change · Q2 20262026-06-26
Shareholder vote results · Q2 20262026-06-12
Quarterly report · Q1 20262026-05-05
Proxy statement · Q2 20262026-04-27
Annual report FY20252026-02-26

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Fortrea Holdings Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.